Italian Multicenter Study on Accuracy of 18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma

被引:13
作者
Cistaro, Angelina [1 ,2 ]
Cassalia, Laura [1 ]
Ferrara, Cinzia [3 ]
Quartuccio, Natale [4 ]
Evangelista, Laura [5 ]
Bianchi, Maurizio [6 ]
Fagioli, Franca [6 ,7 ]
Bisi, Gianni [8 ]
Baldari, Sergio [9 ]
Zanella, Alessandro [10 ]
Pillon, Marta [11 ]
Zucchetta, Pietro [10 ]
Burei, Marta [10 ]
Sala, Alessandra [12 ]
Guerra, Luca [13 ]
Guglielmo, Priscilla [13 ]
Burnelli, Roberta [14 ]
Panareo, Stefano [15 ]
Scalorbi, Federica [16 ]
Rambaldi, Ilaria [15 ]
Piccardo, Arnoldo [17 ]
Garaventa, Alberto [18 ]
Familiari, Demetrio [19 ,20 ]
Fornito, Maria Concetta [19 ,20 ]
Lopci, Egesta [21 ]
Mascarin, Maurizio [22 ]
Altini, Corinna [23 ]
Ferrari, Cristina [23 ]
Perillo, Teresa [24 ]
Santoro, Nicola [24 ]
Borsatti, Eugenio [25 ]
Rubini, Giuseppe [23 ]
机构
[1] IRMET SpA, Positron Emiss Tomog Ctr, Affidea, VO Vigliani 89, I-10136 Turin, Italy
[2] Italian Assoc Nucl Med & Mol Imaging, PET Pediat Study Grp, Milan, Italy
[3] Umberto I Hosp, Nucl Med Unit, Syracuse, NY, Italy
[4] Univ Manchester, Wolfson Mol Imaging Ctr, Manchester, England
[5] Ist Ricovero & Cura Carattere Sci, Ist Oncol Veneto, Nucl Med & Mol Imaging Unit, Padua, Italy
[6] Regina Margherita Childrens Hosp, Pediat Oncohematol & Stem Cell Transplant Div, City Hlth & Sci, Turin, Italy
[7] Italian Assoc Pediat Oncol & Hematol, Turin, Italy
[8] Azienda Osped Univ, Div Nucl Med, Citta Salute & Sci, Turin, Italy
[9] Univ Messina, Dept Biomed Sci & Morphol & Funct Images, Nucl Med Unit, Messina, Italy
[10] Univ Hosp, Dept Med, Nucl Med Serv, Padua, Italy
[11] Univ Hosp Padua, Dept Child & Woman Hlth, Div Hematol Oncol, Padua, Italy
[12] San Gerardo Hosp, MBBM Fdn, Maria Letizia Verga Ctr, Monza, Italy
[13] San Gerardo Hosp, Nucl Med Unit, Monza, Italy
[14] Azienda Osped Univ, Osped SantAnna, Oncoematol Pediat, Ferrara, Italy
[15] S Anna Univ Hosp, Dept Diagnost Imaging, Unit Nucl Med, Ferrara, Italy
[16] Univ Bologna, Nucl Med Unit, Bologna, Italy
[17] EO Galliera Hosp, Dept Diagnost Imaging, Nucl Med Unit, Genoa, Italy
[18] Pediat Ist G Gaslini, Dipartimento Ematol & Oncol, Genoa, Italy
[19] ARNAS Garibaldi Nesima, Nucl Med Dept, Catania, Italy
[20] ARNAS Garibaldi Nesima, PET CT Ctr, Catania, Italy
[21] Humanitas Clin & Res Hosp, Nucl Med Dept, Milan, Italy
[22] Ist Ricovero & Cura Carattere Sci, Ctr Riferimento Oncol Aviano, S S Radioterapia Pediat & Area Giovani, Pordenone, Italy
[23] Nucl Med Unit, Pordenone, Italy
[24] Univ Bari, Dept Pediat, Pediat Hematol Oncol Div, Bari, Italy
[25] Natl Canc Inst, Ist Ricovero & Cura Carattere Sci, Nucl Med Unit, Aviano, Italy
关键词
BMI; Bone marrow biopsy; Computed tomography; Newly diagnosed pediatric HL; Positron emission tomography; POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; RESPONSE ASSESSMENT; INITIAL EVALUATION; FOLLOW-UP; CHILDREN; DISEASE; BIOPSY; ADOLESCENTS; CHILDHOOD;
D O I
10.1016/j.clml.2018.04.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study investigated the utility of fluorine-18 (F-18) fluoro-2-deoxy-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT) in assessing bone marrow involvement (BMI) compared with bone marrow biopsy (BMB) in newly diagnosed pediatric Hodgkin lymphoma (HL). F-18-FDG PET/CT shows high diagnostic performance in evaluating BMI in pediatric HL. BMB should be ideally reserved for patients with doubtful F-18-FDG PET/CT BMI findings. Introduction: The present study investigated the utility of fluorine-18 (F-18) fluoro-2-deoxy-D-glucose (F-18-FDG) positron emission tomography/computed tomography (PET/CT) in assessing bone marrow involvement (BMI) compared with bone marrow biopsy (BMB) in newly diagnosed pediatric Hodgkin lymphoma (HL). Patients and Methods: A total of 224 pediatric patients with HL underwent F-18-FDG PET/CT at staging. BMB or follow-up imaging was used as the standard of reference for the evaluation of BMI. Results: F-18-FDG PET/CT was negative for BMI in 193 cases. Of the 193 patients, the findings for 16 were originally reported as doubtful and later interpreted as negative for BMI, with negative findings on follow-up imaging and BMB. At BMB, 1 of the 16 patients (6.25%) had BMI. Of the 193 patients, 192 (99.48%) had negative BMB findings. Thus, the F-18-FDG PET/CT findings were truly negative for 192 patients and falsely negative for 1 patient for BMI. Conclusion: F-18-FDG PET/CT showed high diagnostic performance in the evaluation of BMI in pediatric HL. Thus, BMB should be ideally reserved for patients presenting with doubtful F-18-FDG PET/CT findings for BMI.
引用
收藏
页码:E267 / E273
页数:7
相关论文
共 49 条
  • [1] Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma
    Adams, Hugo J. A.
    Nievelstein, Rutger A. J.
    Kwee, Thomas C.
    [J]. BLOOD REVIEWS, 2015, 29 (06) : 417 - 425
  • [2] Radionuclide imaging of bone marrow disorders
    Agool, Ali
    Glaudemans, Andor W. J. M.
    Boersma, Hendrikus H.
    Dierckx, Rudi A. J. O.
    Vellenga, Edo
    Slart, Riemer H. J. A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (01) : 166 - 178
  • [3] Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma
    Agrawal, Kanhaiyalal
    Mittal, Bhagwant Rai
    Bansal, Deepak
    Varma, Neelam
    Srinivasan, Radhika
    Trehan, Amita
    Manohar, Kuruva
    Kashyap, Raghava
    Bhattacharya, Anish
    Marwaha, Ram K.
    [J]. ANNALS OF NUCLEAR MEDICINE, 2013, 27 (02) : 146 - 151
  • [4] Evaluation of physiological FDG uptake in the skeleton in adults: Is it uniformly distributed?
    Aras, Mustafa
    Dede, Fuat
    Ones, Tunc
    Inanir, Sabahat
    Erdil, Tanju Yusuf
    Turoglu, Halil Turgut
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2014, 33 (05): : 286 - 289
  • [5] Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
    Barrington, Sally F.
    Mikhaeel, N. George
    Kostakoglu, Lale
    Meignan, Michel
    Hutchings, Martin
    Mueeller, Stefan P.
    Schwartz, Lawrence H.
    Zucca, Emanuele
    Fisher, Richard I.
    Trotman, Judith
    Hoekstra, Otto S.
    Hicks, Rodney J.
    O'Doherty, Michael J.
    Hustinx, Roland
    Biggi, Alberto
    Cheson, Bruce D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 3048 - +
  • [6] ASSESSMENT OF BONE-MARROW HISTOLOGY IN HODGKINS-DISEASE - CORRELATION WITH CLINICAL FACTORS
    BARTL, R
    FRISCH, B
    BURKHARDT, R
    HUHN, D
    PAPPENBERGER, R
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (03) : 345 - 360
  • [7] BILATERAL TREPHINE BONE-MARROW BIOPSIES IN LYMPHOMA AND OTHER NEOPLASTIC DISEASES
    BRUNNING, RD
    BLOOMFIELD, CD
    MCKENNA, RW
    PETERSON, L
    [J]. ANNALS OF INTERNAL MEDICINE, 1975, 82 (03) : 365 - 366
  • [8] CARBONE PP, 1971, CANCER RES, V31, P1860
  • [9] Chen S, 2017, J NUCL MED, V58, p640S
  • [10] The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. accuracy in a multicenter series of 372 patients
    Chen-Liang, Tzu-Hua
    Martin-Santos, Taida
    Jerez, Andres
    Senent, Leonor
    Teresa Orero, Maria
    Jose Remigia, Maria
    Muina, Begona
    Romera, Marta
    Fernandez-Munoz, Hermogenes
    Raya, Jose M.
    Fernandez-Gonzalez, Marta
    Lancharro, Aima
    Villegas, Carolina
    Carlos Herrera, Juan
    Frutos, Laura
    Luis Navarro, Jose
    Una, Jon
    Igua, Carolina
    Sanchez-Vano, Raquel
    del Puig Cozar, Maria
    Contreras, Jose
    Javier Sanchez-Blanco, Jose
    Perez-Ceballos, Elena
    Jose Ortuno, Francisco
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (08) : 686 - 690